Clinical trial

Links Between Inflammation and Cardiometabolic Diseases

NCT01934660

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention 13N-amonia Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Fludeoxyglucose F18 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Links Between Inflammation and Cardiometabolic Diseases

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2013-12-02

PhaseN/A

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Cardiovascular Diseaseverified · MONDO: cardiovascular disorder

Healthy Volunteerunresolved

Inflammationunresolved

Interventions

13N-amoniaDRUG

Fludeoxyglucose F18DRUG

Sponsors & collaborators

National Heart, Lung, and Blood Institute (NHLBI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01934660 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.